Figure 3.
Effect of MEK inhibition on HD cell line viability. (A) Normal peripheral blood lymphocytes (PBLs) and HD cell lines were incubated with UO126 (25 μM) for 48 hours; UO126 had no significant effect on PBLs compared with DMSO alone, while it reduced the number of viable cells of all 4 HD cell lines by 30% to 50%. (B) With the use of the PI staining method, the antiproliferative effect of UO126 (25 μM for 48 hours) was found to be due to either cell-cycle arrest at the G2M phase (percentages shown in the right upper area) or induction of apoptosis (percentages shown in the left upper area). The apoptotic activity of UO126 was most prominent in the HD-LM2, and to a lesser extent, the KM-H2 cell lines. Cell-cycle arrest at the G2M phase was most prominent in the HD-MYZ, L-428, and KM-H2 cell lines. Data shown are representative of 3 independent experiments. Histogram analysis and statistics were generated by using Cellquest software. (C) Induction of apoptosis by UO126 in HD-LM2 cells was confirmed by dual staining with PI and TUNEL. Apoptotic cells are shown in the sub-G0 area (arrowhead), and the percentage of apoptotic cells is shown. The upper 2 boxes show data with RPMI with and without terminal deoxynucleotidyl transferase (TdT). The lower panel shows results obtained after incubation with UO126 for 48 hours.